SCP
PFE icon

Syntal Capital Partners’s Pfizer PFE Stock Holding History

Syntal Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,589
Closed -$451K – 76
2023
Q3 		$451K Sell
13,589
-15,195
-53% -$537K 0.35% 80
2023
Q2 		$1.06M Sell
28,784
-514
-2% -$20K 0.42% 73
2023
Q1 		$1.2M Buy
29,298
+4,010
+16% +$173K 0.44% 75
2022
Q4 		$1.3M Buy
25,288
+1,123
+5% +$53.8K 0.51% 44
2022
Q3 		$1.06M Buy
+24,165
New +$1.17M 0.43% 47
2022
Q1 		– Sell
-20,932
Closed -$1.24M – 104
2021
Q4 		$1.24M Sell
20,932
-13
-0.1% -$644 0.53% 47
2021
Q3 		$900K Sell
20,945
-6,522
-24% -$289K 0.31% 75
2021
Q2 		$1.07M Buy
27,467
+15,991
+139% +$622K 0.38% 81
2021
Q1 		$415K Buy
+11,476
New +$407K 0.16% 96
2019
Q4 		– Sell
-217,214
Closed -$7.4M – 178
2019
Q3 		$7.4M Sell
217,214
-6,618
-3% -$241K 1.92% 11
2019
Q2 		$9.2M Buy
+223,832
New +$8.89M 1.98% 10
2015
Q4 		– Sell
-816
Closed -$24K – 124
2015
Q3 		$24K Buy
816
+2
+0.2% +$64 0.03% 105
2015
Q2 		$25 Buy
814
+1
+0.1% +$33 0.02% 125
2015
Q1 		$26K Buy
813
+2
+0.2% +$64 0.03% 133
2014
Q4 		$23K Buy
811
+2
+0.2% +$57 0.01% 149
2014
Q3 		$22K Buy
809
+177
+28% +$4.97K 0.01% 158
2014
Q2 		$17K Sell
632
-11,004
-95% -$314K 0.01% 178
2014
Q1 		$354 Buy
+11,636
New +$347K 0.21% 40

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Syntal Capital Partners's PFE Position: Q4 2023 in Review

Syntal Capital Partners sold out of Pfizer (PFE) in Q4 2023, closing a stake of 13,589 shares — an estimated $451K sold.

Syntal Capital Partners first reported a position in PFE in Q1 2014 and held it in 18 quarters. The position peaked at $9.2M in Q2 2019. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Syntal Capital Partners reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Syntal Capital Partners sold 13,589 Pfizer shares in Q4 2023, an estimated $451K.
  • Syntal Capital Partners first reported a position in Pfizer in Q1 2014 and held it in 18 quarters.
  • Syntal Capital Partners's Pfizer position peaked at $9.2M in Q2 2019.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Syntal Capital Partners's 13F filing for Q4 2023, filed 13 Feb 2024.